Bright Minds Biosciences

DRUGNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$778.391 M

$79.33 -1.82%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#176Climb BioCLYM$801.7M
#177Monopar TherapeuticsMNPR$798.6M
#178Bright Minds BiosciencesDRUG$778.4M
#179Pharming GroupPHAR$773.3M
#180CryoportCYRX$762.1M

Where these numbers come from

Share counts and financials for Bright Minds Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.